Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 3/2011

01.06.2011 | Clinical Investigation

C-Arm Computed Tomography Compared With Positron Emission Tomography/Computed Tomography for Treatment Planning Before Radioembolization

verfasst von: Christoph Becker, Tobias Waggershauser, Reinhold Tiling, Sabine Weckbach, Thorsten Johnson, Oliver Meissner, Klaus Klingenbeck-Regn, Maximilian Reiser, Ralf Thorsten Hoffmann

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to determine whether rotational C-arm computed tomography (CT) allows visualization of liver metastases and adds relevant information for radioembolization (RE) treatment planning. Technetium angiography, together with C-arm CT, was performed in 47 patients to determine the feasibility for RE. C-arm CT images were compared with positron emission tomography (PET)/CT images for the detection of liver tumors. The images were also rated according one of the following three categories: (1) images that provide no additional information compared with DSA alone; (2) images that do provide additional information compared with DSA; and (2) images that had an impact on eligibility determination for and planning of the RE procedure. In all patients, 283 FDG-positive liver lesions were detected by PET. In venous contrast-phase CT, 221 (78.1%) and 15 (5.3%) of these lesions were either hypodense or hyperdense, respectively. In C-arm CT, 103 (36.4%) liver lesions were not detectable because they were outside of either the field of view or the contrast-enhanced liver segment. Another 25 (8.8%) and 98 (34.6%) of the liver lesions were either hyperdense or presented primarily as hypodense lesions with a rim enhancement, respectively. With PET/CT as the standard of reference, venous CT and C-arm CT failed to detect 47 (16.6%) and 57 (20.1%) of all liver lesions, respectively. For RE planning, C-arm CT provided no further information, provide some additional information, or had an impact on the procedure in 20 (42.5%), 15 (31.9%) and 12 (25.6%) of patients, respectively. We conclude that C-arm CT may add decisive information in patients scheduled for RE.
Literatur
1.
Zurück zum Zitat Cianni R, Urigo C, Notarianni E et al (2009) Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol 32:1179–1186PubMedCrossRef Cianni R, Urigo C, Notarianni E et al (2009) Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol 32:1179–1186PubMedCrossRef
2.
Zurück zum Zitat Bilbao JI, de Martino A, de Luis E et al (2009) Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 32:727–736PubMedCrossRef Bilbao JI, de Martino A, de Luis E et al (2009) Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 32:727–736PubMedCrossRef
3.
Zurück zum Zitat Salem R, Lewandowski R, Sato K et al (2007) Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10:12–29PubMedCrossRef Salem R, Lewandowski R, Sato K et al (2007) Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10:12–29PubMedCrossRef
4.
Zurück zum Zitat Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278PubMedCrossRef Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278PubMedCrossRef
5.
Zurück zum Zitat Gulec SA, Fong Y (2007) Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 142:675–682PubMedCrossRef Gulec SA, Fong Y (2007) Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 142:675–682PubMedCrossRef
6.
Zurück zum Zitat Kalender WA, Kyriakou Y (2007) Flat-detector computed tomography (FD-CT). Eur Radiol 17:2767–2779PubMedCrossRef Kalender WA, Kyriakou Y (2007) Flat-detector computed tomography (FD-CT). Eur Radiol 17:2767–2779PubMedCrossRef
7.
Zurück zum Zitat Welsh JS, Kennedy AS, Thomadsen B (2006) Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62–S73PubMed Welsh JS, Kennedy AS, Thomadsen B (2006) Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62–S73PubMed
8.
Zurück zum Zitat Lewandowski RJ, Thurston KG, Goin JE et al (2005) 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135–150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16:1641–1651PubMed Lewandowski RJ, Thurston KG, Goin JE et al (2005) 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135–150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16:1641–1651PubMed
9.
Zurück zum Zitat Salem R, Lewandowski R, Roberts C et al (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345PubMedCrossRef Salem R, Lewandowski R, Roberts C et al (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345PubMedCrossRef
10.
Zurück zum Zitat Bangash AK, Atassi B, Kaklamani V et al (2007) 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18:621–628PubMedCrossRef Bangash AK, Atassi B, Kaklamani V et al (2007) 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18:621–628PubMedCrossRef
11.
Zurück zum Zitat Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935PubMed Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935PubMed
12.
Zurück zum Zitat Haydar AA, Wasan H, Wilson C, Tait P (2010) 90Y radioembolization: embolization of the gastroduodenal artery is not always appropriate. Cardiovasc Intervent Radiol. doi:10.1007/s00270-010-9838-6 Haydar AA, Wasan H, Wilson C, Tait P (2010) 90Y radioembolization: embolization of the gastroduodenal artery is not always appropriate. Cardiovasc Intervent Radiol. doi:10.​1007/​s00270-010-9838-6
13.
Zurück zum Zitat Bilbao JI, Garrastachu P, Herráiz MJ et al (2009) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol. doi:10.1007/s00270-009-9717-1 Bilbao JI, Garrastachu P, Herráiz MJ et al (2009) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol. doi:10.​1007/​s00270-009-9717-1
14.
Zurück zum Zitat Heusner TA, Hamami ME, Ertle J et al (2010) Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo [Epub ahead of print] Heusner TA, Hamami ME, Ertle J et al (2010) Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo [Epub ahead of print]
15.
Zurück zum Zitat Louie JD, Kothary N, Kuo WT et al (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20:606–613PubMedCrossRef Louie JD, Kothary N, Kuo WT et al (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20:606–613PubMedCrossRef
16.
Zurück zum Zitat Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W (2009) Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT. J Vasc Interv Radiol 20:422–424PubMedCrossRef Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W (2009) Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT. J Vasc Interv Radiol 20:422–424PubMedCrossRef
17.
Zurück zum Zitat Ibrahim SM, Lewandowski RJ, Ryu RK et al (2008) Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol 31:1124–1132PubMedCrossRef Ibrahim SM, Lewandowski RJ, Ryu RK et al (2008) Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol 31:1124–1132PubMedCrossRef
Metadaten
Titel
C-Arm Computed Tomography Compared With Positron Emission Tomography/Computed Tomography for Treatment Planning Before Radioembolization
verfasst von
Christoph Becker
Tobias Waggershauser
Reinhold Tiling
Sabine Weckbach
Thorsten Johnson
Oliver Meissner
Klaus Klingenbeck-Regn
Maximilian Reiser
Ralf Thorsten Hoffmann
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 3/2011
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-9897-8

Weitere Artikel der Ausgabe 3/2011

CardioVascular and Interventional Radiology 3/2011 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.